What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Surgery
Anna T. Meadows focuses on Surgery, Cancer, Radiation therapy, Childhood Cancer Survivor Study and Internal medicine.
Her Surgery research incorporates themes from Retinopathy and Metastasis.
Anna T. Meadows combines subjects such as Psychiatry and Disease with her study of Cancer.
Her Radiation therapy study integrates concerns from other disciplines, such as El Niño, Epidemiology of cancer, Chemotherapy and Gynecology.
Her Childhood Cancer Survivor Study research is multidisciplinary, incorporating elements of Relative risk, Absolute risk reduction, Pediatrics and Cohort study.
The concepts of her Internal medicine study are interwoven with issues in Evidence-based medicine, Oncology and Nursing care.
Her most cited work include:
- Chronic Health Conditions in Adult Survivors of Childhood Cancer (2470 citations)
- Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's Disease (781 citations)
- Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer: Childhood Cancer Survivor Study (613 citations)
What are the main themes of her work throughout her whole career to date?
Anna T. Meadows spends much of her time researching Internal medicine, Cancer, Surgery, Oncology and Pediatrics.
Her studies in Internal medicine integrate themes in fields like Gastroenterology and Endocrinology.
The various areas that Anna T. Meadows examines in her Cancer study include Incidence, Risk factor and Pathology.
Much of her study explores Surgery relationship to Retinoblastoma.
Her research in Pediatrics tackles topics such as Childhood cancer which are related to areas like Psychiatry.
Her study in Childhood Cancer Survivor Study is interdisciplinary in nature, drawing from both Cohort study, Relative risk, Retrospective cohort study, Cumulative incidence and Cohort.
She most often published in these fields:
- Internal medicine (35.40%)
- Cancer (30.93%)
- Surgery (29.55%)
What were the highlights of her more recent work (between 2006-2020)?
- Internal medicine (35.40%)
- Cancer (30.93%)
- Oncology (21.99%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Internal medicine, Cancer, Oncology, Retinoblastoma and Childhood Cancer Survivor Study.
Her research in Internal medicine intersects with topics in Immunology and Chromosome, Karyotype.
Her Cancer study combines topics from a wide range of disciplines, such as Young adult, Cumulative incidence, Pediatrics and Risk factor.
Her work carried out in the field of Retinoblastoma brings together such families of science as Eye disease, Surgery, Pineoblastoma and Pathology.
The Surgery study which covers Sarcoma that intersects with Anthracycline.
Her studies in Childhood Cancer Survivor Study integrate themes in fields like Incidence, Cohort study, Relative risk, Retrospective cohort study and Cohort.
Between 2006 and 2020, her most popular works were:
- The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research (471 citations)
- Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study (459 citations)
- Second Neoplasms in Survivors of Childhood Cancer: Findings From the Childhood Cancer Survivor Study Cohort (381 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Disease
Anna T. Meadows mainly investigates Cancer, Childhood Cancer Survivor Study, Pediatric cancer, Young adult and Pediatrics.
Her Cancer research includes themes of Gynecology and Radiation therapy.
The various areas that she examines in her Childhood Cancer Survivor Study study include Relative risk, Cohort study and Risk factor.
Anna T. Meadows usually deals with Relative risk and limits it to topics linked to Absolute risk reduction and Surgery, Hazard ratio and Sarcoma.
Her Surgery research includes elements of Ophthalmology and Retinoblastoma.
Her Pediatrics study combines topics in areas such as Incidence, Cumulative incidence and Skin cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
